Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 007045 USA, NDC 0591-2132-01
Published February 9, 2022 · Recall initiated: January 18, 2022
Summary
FDA records drug Class II recall D-0461-2022, published February 9, 2022 and initiated January 18, 2022. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 6205 100-count bottles; Lot: Lot# 100025842, 100028023, Exp Date 08/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient
What to do
Voluntary: Firm initiated
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Nationwide in the USA
- Lot
- Lot# 100025842, 100028023, Exp Date 08/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADoxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADESeptember 9, 2026
- FDAMedroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single Dose Vial, RX Only, IdealFebruary 9, 2022
- FDANasal & Sinus Decongestant (phenylephrine HCl 5mg) 2 tablets per packet, Mfd. for Cintas First Aid & Safety,February 9, 2022
- FDAGE Vscan Extend, being sold as "Vscan Extend Sector DICOM"February 2, 2022
- FDAGE Vscan Extend, being sold as "Vscan Extend Dual Wi-Fi"February 2, 2022
- FDAGE Vscan Extend, being sold as "Vscan Extend Dual USB"February 2, 2022
Questions about this recall
Was Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 007045 USA, NDC 0591-2132-01 recalled?
Yes. FDA published recall D-0461-2022 on February 9, 2022. Reported hazard: Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE.